Opportunistic and Other Infections in HIV-Infected Children in Latin America Compared to a Similar Cohort in the United States

Instituto de Medicina Tropical, UNMSM, Lima, Perú.
AIDS research and human retroviruses (Impact Factor: 2.46). 09/2011; 28(3):282-8. DOI: 10.1089/AID.2011.0057
Source: PubMed

ABSTRACT Opportunistic and other infections have declined since the introduction of highly active antiretroviral therapy (HAART) in developed countries but few studies have addressed the impact of HAART in HIV-infected children from developing countries. This study examines the prevalence and incidence of opportunistic and other infections in Latin America during the HAART era. Vertically HIV-infected children enrolled in a cohort study between 2002 and 2007 were followed for the occurrence of 29 targeted infections. Cross-sectional and longitudinal analyses were performed to calculate the prevalence of infections before enrollment and the incidence rates of opportunistic and other infections after enrollment. Comparisons were made with data from a U.S. cohort (PACTG 219C). Of the 731 vertically HIV-infected children 568 (78%) had at least one opportunistic or other infection prior to enrollment. The most prevalent infections were bacterial pneumonia, oral candidiasis, varicella, tuberculosis, herpes zoster, and Pneumocystis jiroveci pneumonia. After enrollment, the overall incidence was 23.5 per 100 person-years; the most common infections (per 100 person-years) were bacterial pneumonia (7.8), varicella (3.0), dermatophyte infections (2.9), herpes simplex (2.5), and herpes zoster (1.8). All of these incidence rates were higher than those reported in PACTG 219C. The types and relative distribution of infections among HIV-infected children in Latin America in this study are similar to those seen in the United States but the incidence rates are higher. Further research is necessary to determine the reasons for these higher rates.

Download full-text


Available from: Mary F. Reyes Vega, May 15, 2014
1 Follower
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Headache occurs worldwide, but documentation on the burden of headache in Saudi communities is quite limited. The aim of this study was to determine the prevalence of primary headache in a rural community in the Qassim region of Saudi Arabia. A door-to-door survey of subjects older than 15 years of age was used for completion of a structured questionnaire to determine headache types based on defined criteria. Physical examination was used to exclude secondary causes. Of 5891 inhabitants, 473 suffered from headaches. The crude lifetime prevalence rate was 8% (95% Cl, 7.3% to 8.7%) and with age adjustment was 9.3% (8.6% to 10%). Headache sufferers were predominantly women. The age-specific rate increased progressively, peaking in the sixth decade. Tension-type headache diagnosed in 185 subjects predominated (3.1%), while the prevalence of migraine was 2.6%. The findings agree with the reported prevalence of 10% to 12% in other communities in the Kingdom of Saudi Arabia, but lower than the rates in Western countries. The lower rates are probably related to sociocultural factors.
    Headache The Journal of Head and Face Pain 07/1996; 36(6):385-8. · 3.19 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This study was performed to investigate frequency and antimicrobial susceptibility of pulmonary pathogens in cystic fibrosis (CF) patients. 129 pediatric patients with CF were enrolled in this cross-sectional study. Microbiological cultures were performed based on sputum or pharyngeal swabs. Antibiotic susceptibilities of the isolated bacteria were determined by the disk diffusion method. The main infecting pathogens were Pseudomonas aeruginosa (38.8%), Klebsiella pneumoniae (11.6%) and Staphyloccus areus (9.3%), respectively. The most active antibiotics included rifampin (91.7% susceptibility), vancomycin (85%) and imipenem (83.5%). Emerging resistance against aminoglycosides was observed. Regarding in vitro susceptibility results, cyclic treatment of long-term oral azithromycin and inhaled tobramycin could prophylactically be applied, and during exacerbations, imipenem or ceftazidime in combination with an aminoglycoside such as amikacin could be considered the drugs of choice.
    Brazilian Journal of Infectious Diseases 04/2012; 16(2):122-8. DOI:10.1016/S1413-8670(12)70292-1 · 1.10 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Desde que se conoció la infección por el virus de la inmunodeficiencia humana (VIH), se han diagnosticado más de 2,5 millones de niños infectados a nivel mundial. Con este conocimiento vino también la generación del tratamiento HAART (Highly Active Antiretroviral Therapy), que logró mejorar la calidad de vida y la expectativa de vida de los lactantes infectados. Sin embargo, los individuos que reciben tratamiento presentan condiciones particulares que los hacen constituir un grupo de individuos con necesidades de atención y cuidado diferentes. En esta revisión se abordan los aspectos clínicos más relevantes que aquejan a los niños infectados por VIH que reciben tratamiento antirretroviral altamente activo.
    06/2012; 16(2):122-127.
Show more